Trial Profile
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 02 Oct 2023
Price :
$35
*
At a glance
- Drugs Argatroban (Primary) ; Warfarin
- Indications Embolism and thrombosis; Vascular graft occlusion
- Focus Therapeutic Use
- 09 Mar 2012 Actual patient number 9 added as reported by ClinicalTrials.gov.
- 09 Mar 2012 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.